Boryung Consumer Healthcare Co., Ltd. announced on the 28th that it recently held a general meeting of shareholders and a board of directors meeting, and appointed Jung Woongje, Head of Sales at Boryung Co., Ltd., as its new CEO.

Jung Woongje, newly appointed CEO of Boryung Consumer Healthcare Co., Ltd. Boryung

Jung Woongje, newly appointed CEO of Boryung Consumer Healthcare Co., Ltd. Boryung

View original image

CEO Jung Woongje is a pharmaceutical sales expert who previously served as Executive Director at Hanmi Pharmaceutical and joined Boryung in 2017. Since then, he has led the Physician Sales Division and the Sales Division, overseeing the entire sales and marketing process from strategy development to field execution. He has contributed to the company's profit generation through rapid market response and strong execution capabilities.


This appointment was made to strengthen the competitiveness of Boryung Consumer Healthcare's sales organization, fundamentally improve the company's structure, and enhance profitability.


Jung Woongje, the new CEO, stated, "Based on the experience I have accumulated in the sales field, I will strive to build a solid foundation for sustainable and substantial growth through efficient organizational management, while also enhancing corporate value by developing consumer-oriented products."



Boryung Consumer Healthcare, a subsidiary of Boryung Co., Ltd., is a healthcare-specialized company. It leads the creation of a healthy lifestyle culture by offering a wide range of products, including over-the-counter pharmaceuticals, health functional foods, quasi-drugs, and medical devices.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing